A Detailed Summary
This factsheet provides clinicians with essential guidance on sacrosidase replacement therapy for managing Congenital Sucrase-Isomaltase Deficiency (CSID), the only FDA-approved enzyme therapy derived from baker’s yeast that effectively hydrolyses sucrose. It outlines practical dosing instructions for Sucraid® Oral Solution, safety considerations and strategies to help patients reduce dietary restrictions while minimising malabsorption symptoms. By offering evidence-based insights, this resource empowers clinicians to optimise treatment plans and improve outcomes for both paediatric and adult CSID patients.
Our member downloads
Our factsheets are free to download for GI Institute Members. Our members have access to our ever-growing multilingual library of factsheets that are designed to assist your learning or to provide to your patients in your clinic.
